Linear IgA disease: The IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 977-985

  Allen, J ^a   Wojnarowska, F ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibody isotypes; Epidermal extracts; Epitope spreading; Immunoblotting; Linear IgA disease; Target antigens

Indexed keywords

ANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN TYPE 17; DAPSONE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LAD285 ANTIGEN; UNCLASSIFIED DRUG; UREA;

ADULT; AGE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; BULLOUS SKIN DISEASE; CHILD; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LINEAR IMMUNOGLOBULIN A DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; CHILD; CHILD, PRESCHOOL; EPIDERMIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; SKIN DISEASES, VESICULOBULLOUS;

EID: 0346770033     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05648.x     Document Type: Article

References (36)

1. Haftek M, Zone J, Taylor T et al. Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patient serum. J Invest Dermatol 1994; 103: 656-9.
2. Zhou S, Ferguson DJP, Allen J, Wojnarowska F. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting. Br J Dermatol 1998; 139: 591-7.
3. Karpati S, Stolz W, Meurer M et al. Ultrastructural immunogold studies in two cases of linear IgA dermatosis. Are there two distinct types of this disease? Br J Dermatol 1992; 127: 112-18.
4. Ishiko A, Shimizu H, Masunaga T et al. 97-kDa Linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. J Invest Dermatol 1996; 106: 739-43.
5. Zambruno G, Manca V, Kanitakis J et al. Linear IgA bullous dermatosis with autoantibodies to a 290kd antigen of anchoring fibrils. J Am Acad Dermatol 1994; 31: 884-8.
6. Hashimoto T, Ishiko A, Shimizu H et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol 1996; 134: 336-9.
7. Collier P, Wojnarowska F, Allen J, Kirtschig G. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Dermatology 1994; 189 (Suppl. 1): 105-7.
8. Zone J, Taylor T, Kadunce D, Meyer L. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990; 85: 812-20.
9. Marinkovich P, Taylor T, Keene D et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-8.
10. Pas HH, Kloosterhuis GJ, Heeres K et al. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 1997; 108: 423-9.
11. Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180-or 230-kDa epidermal antigens. J Invest Dermatol 1997; 108: 854-8.
12. Zone J, Taylor T, Meyer L, Peterson M. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen. BPAg2. J Invest Dermatol 1998; 110: 207-10.
13. Zillikens D, Herzele K, Georgi M et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180. J Invest Dermatol 1999; 113: 947-53.
14. Schumann H, Baetge J, Tasanen K et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000; 156: 685-95.
15. Roh JY, Yee C, Lazarova Z et al. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000; 143: 104-11.
16. Christophoridis S, Budinger L, Borradori L et al. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid, and linear IgA bullous dermatosis. Br J Dermatol 2000; 143: 349-55.
17. Bedane C, McMillan J, Balding S et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997; 108: 901-7.
18. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998; 139: 365-70.
19. Guidice C, Emery D, Diaz I. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992; 99: 243-50.
20. Guidice C, Emery D, Zelickson B et al. Bullous pemphigoid and herpes gestationis autoantibodies recognise a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-50.
21. Zillikens D, Caux F, Mascaro J et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999; 113: 117-21.
22. Kanitakis J, Mauduit G, Cozzani E et al. Linear IgA bullous dermatosis of childhood with auto antibodies to a 230 kDa epidermal antigen. Pediatr Dermatol 1994; 11: 139-44.
23. Allen J, Zhou S, Wakelin S et al. Linear IgA disease: a report of two dermal binding sera which recognize a pepsin-sensitive epitope (?NC-1 domain) of collagen type VII. Br J Dermatol 1997; 137: 526-33.
24. Fujimoto W, Ohtsu T, Toi Y et al. Linear IgA disease with IgA antibodies directed against 200-and 280-kDa epidermal antigens. Br J Dermatol 2000; 142: 1213-18.
25. Wojnarowska F, Whitehead P, Leigh I et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991; 124: 157-62.
26. Dmochowski M, Hashimoto T, Bhogal B et al. Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993; 6: 194-200.
27. Sheridan AT, Kirtschig G, Wojnarowska F. Mixed immunobullous disease: is this linear IgA disease? Australas J Dermatol 2000; 41: 219-21.
28. Powell J, Kirtschig G, Allen J et al. Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol 2001; 144: 769-74.
29. Setterfield J, Shirlaw PJ, Kerr-Muir M et al. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998; 138: 602-10.
30. Kromminga A, Scheckenbach C, Georgi M et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000; 15: 293-300.
31. Wojnarowska F, Allen J, Collier P, Leigh I. A comparison of the expression of known basement membrane components with linear IgA disease antigens using the novel substrate cylindroma. Br J Dermatol 1998; 139: 591-7.
32. Allen J, Wojnarowska F. Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein. Br J Dermatol 2003; 149: 1055-8.
33. Petit A, Perrin P, Bernard P et al. A case of cicatricial pemphigoid with circulating IgA and IgG antibodies directed against 280 kD, 165 kD and 120-130 kD epidermal antigens. Acta Derm Venereol (Stockh) 1990; 70: 236-8.
34. Kirtschig G, Wojnarowska F. IgA basement membrane zone antibodies in bullous pemphigoid detect epidermal antigens of 270-280 kDa and 180 kDa molecular weight by immunoblotting. Clin Exp Dermatol 1999; 24: 302-7.
35. Stanley J, Hawley-Nelson P, Yuspa S et al. Characterization of bullous pemphigoid antigen - a unique basement membrane protein of stratified squamous epithelia. Cell 1981; 24: 897-903.
36. Chan L, Vanderlug C, Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110: 103-9.